Business

Clover Health to Present at Citi's 2023 Healthcare Conference on March 1, 2023

FRANKLIN, Tenn., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician

articleClover Health Investments, Corp.February 22, 20233/company/clover-health-investments-corp/news/clover-health-to-present-at-citis-2023-healthcare-conference-on-march-1-2023-2023-02
Clover Health to Present at Citi's 2023 Healthcare Conference on March 1, 2023

About this update from Clover Health Investments, Corp.

[{"type":"text","content":"FRANKLIN, Tenn., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Andrew Toy, will present at Citi's 2023 Healthcare Conference on Wednesday, March 1, 2023, at 8:45 a.m. Eastern Time. A live webcast of the presentation will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/. An archived replay of the presentation will be available from the same website for 12 months following the live presentation. About Clover Health:Clover Health (Nasdaq: CLOV) is a physician enablement company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes. We operate two distinct lines of business: Insurance and Non-Insurance. Through our Insurance line of business, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. Our Non-Insurance line of business similarly aims to reduce cost-of-care while enhancing the quality of care for patients enrolled in Original Medicare. Press Contact:Andrew Still-BaxterEmma [email protected] Investor Relations Contact:Ryan [email protected] \nSource: Clover Health Investments, Corp.","length":3731,"tagName":"div"}]

More updates from Clover Health Investments, Corp.